Hear valuable insights in this panel discussion on the future of clinical manufacturing, including regulatory hurdles, industry-regulator partnerships, and strategies for successful drug development.

Collaboration, communication, and competition are key to advancing cell and gene therapy. Experts share insights from Cencora's inaugural CGT summit.

Explore insights from George Eastwood at the ThinkLive Cell and Gene Therapy Summit 2024 on enhancing therapies and advancing patient-centric drug development.

Discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.

Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.

Dive into this overview of the evolving regulatory landscape and better understand the importance of proactive planning, collaboration, and expert guidance in navigating the ATMPs ecosystem in Europe.

Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.

Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.

Watch this panel of regulatory experts taking part in an interactive roundtable examining the benefits of establishing standard terminology and its potential to help significantly improve regulatory quality, data accuracy, and efficiency.

The new Clinical Trials Regulation (EU) 536/2014 has raised critical questions about business process and data interactions between Clinical and Regulatory in biopharmaceutical companies. Did you know that as of 6 March 2022, there were more than 200 draft applications in CTIS?